Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study

[1] André T(2020)Pembrolizumab in microsatellite-instability–high advanced colorectal cancer N Eng J Med 383 2207-2218

[2] Shiu KK(2005)The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer Color Dis 7 214-217

[3] Kim TW(2019)Biomarker concordance between primary colorectal cancer and its metastases EBioMedicine 40 363-374

[4] Jensen BV(2014)Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions Genome Biol 15 1-10

[5] Jensen LH(2022)Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up Ann Oncol S0923–7534 04192-4198

[6] Punt C(2016)Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: identification of driver and passenger mutations J Pathol Clin Res 2 166-174

[7] Smith D(2020)Microsatellite instability screening in colorectal adenomas to detect lynch syndrome patients? A systematic review and meta-analysis Eur J Hum Genet 28 277-286

[8] Banerjee S(2017)High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases Oncol Rep 37 785-792

[9] Kapur S(2012)Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary Clin Colorectal Cancer 11 191-194

[10] Moran BJ(2008)The differential response to chemotherapy of ovarian metastases from colorectal carcinoma Eur J Surg Oncol 34 1335-1339

[1] André T(2020)Pembrolizumab in microsatellite-instability–high advanced colorectal cancer N Eng J Med 383 2207-2218

[2] Shiu KK(2005)The role of prophylactic oophorectomy in women undergoing surgery for colorectal cancer Color Dis 7 214-217

[3] Kim TW(2019)Biomarker concordance between primary colorectal cancer and its metastases EBioMedicine 40 363-374

[4] Jensen BV(2014)Comparative sequencing analysis reveals high genomic concordance between matched primary and metastatic colorectal cancer lesions Genome Biol 15 1-10

[5] Jensen LH(2022)Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up Ann Oncol S0923–7534 04192-4198

[6] Punt C(2016)Somatic mutation profiles in primary colorectal cancers and matching ovarian metastases: identification of driver and passenger mutations J Pathol Clin Res 2 166-174

[7] Smith D(2020)Microsatellite instability screening in colorectal adenomas to detect lynch syndrome patients? A systematic review and meta-analysis Eur J Hum Genet 28 277-286

[8] Banerjee S(2017)High concordance rate of KRAS/BRAF mutations and MSI-H between primary colorectal cancer and corresponding metastases Oncol Rep 37 785-792

[9] Kapur S(2012)Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary Clin Colorectal Cancer 11 191-194

[10] Moran BJ(2008)The differential response to chemotherapy of ovarian metastases from colorectal carcinoma Eur J Surg Oncol 34 1335-1339